Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation

Federica Sora', Patrizia Chiusolo, Luca Laurenti, Gina Zini, Simona Sica, Elisabetta Metafuni, Silvia Bellesi, Sabrina Giammarco, Giuseppe Ausoni, Giuseppe Leone, Aj Bayer, B Mario

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

sorafenib after stem cell transplantation
Original languageEnglish
Pages (from-to)422-423
Number of pages2
JournalLeukemia Research
Volume35
DOIs
Publication statusPublished - 2011

Keywords

  • Adult
  • Antineoplastic Agents
  • Benzenesulfonates
  • Drug Resistance, Neoplasm
  • Gastrointestinal Diseases
  • Graft vs Host Disease
  • Humans
  • Inverted Repeat Sequences
  • Leukemia, Myeloid, Acute
  • Male
  • Middle Aged
  • Mutation
  • Pyridines
  • Salvage Therapy
  • Skin Diseases
  • Stem Cell Transplantation
  • Tandem Repeat Sequences
  • Transplantation, Homologous
  • Young Adult
  • fms-Like Tyrosine Kinase 3

Fingerprint

Dive into the research topics of 'Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation'. Together they form a unique fingerprint.

Cite this